Unlike TKI-sensitive HCC827 cells, the intracellular level of LPIN1 was transcriptionally induced by gefitinib treatment in TKI-resistant H1650 and patient-derived TKI-resistant lung cancer cells. The gene discussed is LPIN1; the disease is lung cancer.